SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '1r5l'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site

Query pattern: Residues from known binding site for annotated drug that match the hit pattern


(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID
Hit
Macromolecule
Res.
Matches
Interface HETATM RMSD Dali
Z-score
Seq.
Identity (%)
View Dock
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1OIP_A_VIVA1278_0
(ALPHA-TOCOPHEROL
TRANSFER PROTEIN)
1r5l PROTEIN
(ALPHA-TOCOPHEROL
TRANSFER PROTEIN)

(Homo
sapiens)
12 / 12 TYR A 100
ILE A 119
TRP A 122
VAL A 132
LEU A 137
ILE A 154
ILE A 171
ILE A 179
LEU A 183
VAL A 191
ILE A 194
ILE A 210
None
None
None
VIV  A 301 ( 4.7A)
VIV  A 301 ( 4.8A)
None
None
VIV  A 301 ( 4.0A)
None
VIV  A 301 (-4.7A)
VIV  A 301 ( 4.5A)
None
0.23A 1oipA-1r5lA:
43.4
1oipA-1r5lA:
93.17
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1OIP_A_VIVA1278_1
(ALPHA-TOCOPHEROL
TRANSFER PROTEIN)
1r5l PROTEIN
(ALPHA-TOCOPHEROL
TRANSFER PROTEIN)

(Homo
sapiens)
5 / 5 SER A 136
SER A 140
PHE A 158
VAL A 182
PHE A 187
VIV  A 301 (-3.5A)
VIV  A 301 (-3.1A)
VIV  A 301 (-3.9A)
VIV  A 301 (-4.5A)
VIV  A 301 (-3.9A)
0.28A 1oipA-1r5lA:
43.4
1oipA-1r5lA:
93.17
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1R5L_A_VIVA301_0
(PROTEIN
(ALPHA-TOCOPHEROL
TRANSFER PROTEIN))
1r5l PROTEIN
(ALPHA-TOCOPHEROL
TRANSFER PROTEIN)

(Homo
sapiens)
12 / 12 TRP A 122
VAL A 132
PHE A 133
ILE A 154
PHE A 158
TRP A 163
ILE A 171
ILE A 179
VAL A 182
VAL A 191
ILE A 194
ILE A 210
None
VIV  A 301 ( 4.7A)
VIV  A 301 ( 3.9A)
None
VIV  A 301 (-3.9A)
None
None
VIV  A 301 ( 4.0A)
VIV  A 301 (-4.5A)
VIV  A 301 (-4.7A)
VIV  A 301 ( 4.5A)
None
0.02A 1r5lA-1r5lA:
45.9
1r5lA-1r5lA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1R5L_A_VIVA301_0
(PROTEIN
(ALPHA-TOCOPHEROL
TRANSFER PROTEIN))
1r5l PROTEIN
(ALPHA-TOCOPHEROL
TRANSFER PROTEIN)

(Homo
sapiens)
5 / 12 VAL A 135
PHE A 133
PHE A 158
VAL A 182
ILE A 194
None
VIV  A 301 ( 3.9A)
VIV  A 301 (-3.9A)
VIV  A 301 (-4.5A)
VIV  A 301 ( 4.5A)
1.34A 1r5lA-1r5lA:
45.9
1r5lA-1r5lA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1R5L_A_VIVA301_1
(PROTEIN
(ALPHA-TOCOPHEROL
TRANSFER PROTEIN))
1r5l PROTEIN
(ALPHA-TOCOPHEROL
TRANSFER PROTEIN)

(Homo
sapiens)
4 / 4 SER A 136
SER A 140
LEU A 183
PHE A 187
VIV  A 301 (-3.5A)
VIV  A 301 (-3.1A)
None
VIV  A 301 (-3.9A)
0.03A 1r5lA-1r5lA:
45.9
1r5lA-1r5lA:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1RJO_A_CUA701_0
(PHENYLETHYLAMINE
OXIDASE)
1r5l PROTEIN
(ALPHA-TOCOPHEROL
TRANSFER PROTEIN)

(Homo
sapiens)
3 / 3 HIS A 195
HIS A 225
HIS A 236
None
0.69A 1rjoA-1r5lA:
undetectable
1rjoA-1r5lA:
18.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1UPF_B_URFB999_1
(URACIL
PHOSPHORIBOSYLTRANSF
ERASE)
1r5l PROTEIN
(ALPHA-TOCOPHEROL
TRANSFER PROTEIN)

(Homo
sapiens)
4 / 7 ALA A 168
ILE A 171
ILE A 210
PHE A 207
None
0.88A 1upfB-1r5lA:
undetectable
1upfB-1r5lA:
21.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1VQ1_A_SAMA301_0
(N5-GLUTAMINE
METHYLTRANSFERASE,
HEMK)
1r5l PROTEIN
(ALPHA-TOCOPHEROL
TRANSFER PROTEIN)

(Homo
sapiens)
5 / 12 ILE A 218
ALA A 176
ILE A 179
THR A 215
GLU A 220
None
None
VIV  A 301 ( 4.0A)
None
None
1.29A 1vq1A-1r5lA:
undetectable
1vq1A-1r5lA:
26.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1W2Z_A_CUA701_0
(AMINE OXIDASE,
COPPER CONTAINING)
1r5l PROTEIN
(ALPHA-TOCOPHEROL
TRANSFER PROTEIN)

(Homo
sapiens)
3 / 3 HIS A 195
HIS A 225
HIS A 236
None
0.74A 1w2zA-1r5lA:
undetectable
1w2zA-1r5lA:
18.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1W2Z_B_CUB701_0
(AMINE OXIDASE,
COPPER CONTAINING)
1r5l PROTEIN
(ALPHA-TOCOPHEROL
TRANSFER PROTEIN)

(Homo
sapiens)
3 / 3 HIS A 195
HIS A 225
HIS A 236
None
0.69A 1w2zB-1r5lA:
undetectable
1w2zB-1r5lA:
18.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1W2Z_C_CUC701_0
(AMINE OXIDASE,
COPPER CONTAINING)
1r5l PROTEIN
(ALPHA-TOCOPHEROL
TRANSFER PROTEIN)

(Homo
sapiens)
3 / 3 HIS A 195
HIS A 225
HIS A 236
None
0.68A 1w2zC-1r5lA:
undetectable
1w2zC-1r5lA:
18.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1W2Z_D_CUD701_0
(AMINE OXIDASE,
COPPER CONTAINING)
1r5l PROTEIN
(ALPHA-TOCOPHEROL
TRANSFER PROTEIN)

(Homo
sapiens)
3 / 3 HIS A 195
HIS A 225
HIS A 236
None
0.68A 1w2zD-1r5lA:
undetectable
1w2zD-1r5lA:
18.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2OQE_A_CUA801_0
(PEROXISOMAL COPPER
AMINE OXIDASE)
1r5l PROTEIN
(ALPHA-TOCOPHEROL
TRANSFER PROTEIN)

(Homo
sapiens)
3 / 3 HIS A 195
HIS A 225
HIS A 236
None
0.71A 2oqeA-1r5lA:
undetectable
2oqeA-1r5lA:
17.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2OQE_B_CUB801_0
(PEROXISOMAL COPPER
AMINE OXIDASE)
1r5l PROTEIN
(ALPHA-TOCOPHEROL
TRANSFER PROTEIN)

(Homo
sapiens)
3 / 3 HIS A 195
HIS A 225
HIS A 236
None
0.70A 2oqeB-1r5lA:
undetectable
2oqeB-1r5lA:
17.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2OQE_C_CUC801_0
(PEROXISOMAL COPPER
AMINE OXIDASE)
1r5l PROTEIN
(ALPHA-TOCOPHEROL
TRANSFER PROTEIN)

(Homo
sapiens)
3 / 3 HIS A 195
HIS A 225
HIS A 236
None
0.72A 2oqeC-1r5lA:
undetectable
2oqeC-1r5lA:
17.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2OQE_D_CUD801_0
(PEROXISOMAL COPPER
AMINE OXIDASE)
1r5l PROTEIN
(ALPHA-TOCOPHEROL
TRANSFER PROTEIN)

(Homo
sapiens)
3 / 3 HIS A 195
HIS A 225
HIS A 236
None
0.70A 2oqeD-1r5lA:
undetectable
2oqeD-1r5lA:
17.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2OQE_F_CUF801_0
(PEROXISOMAL COPPER
AMINE OXIDASE)
1r5l PROTEIN
(ALPHA-TOCOPHEROL
TRANSFER PROTEIN)

(Homo
sapiens)
3 / 3 HIS A 195
HIS A 225
HIS A 236
None
0.71A 2oqeF-1r5lA:
undetectable
2oqeF-1r5lA:
17.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2PRG_A_BRLA1_2
(PEROXISOME
PROLIFERATOR
ACTIVATED RECEPTOR
GAMMA)
1r5l PROTEIN
(ALPHA-TOCOPHEROL
TRANSFER PROTEIN)

(Homo
sapiens)
3 / 3 ILE A 116
ILE A 197
LEU A  95
None
0.40A 2prgA-1r5lA:
undetectable
2prgA-1r5lA:
21.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3R9V_B_DXCB1_0
(INVASIN IPAD)
1r5l PROTEIN
(ALPHA-TOCOPHEROL
TRANSFER PROTEIN)

(Homo
sapiens)
4 / 7 ILE A 179
LEU A 183
SER A 140
VAL A 103
VIV  A 301 ( 4.0A)
None
VIV  A 301 (-3.1A)
None
0.98A 3r9vA-1r5lA:
undetectable
3r9vB-1r5lA:
undetectable
3r9vA-1r5lA:
21.78
3r9vB-1r5lA:
21.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3W67_A_VIVA301_0
(ALPHA-TOCOPHEROL
TRANSFER PROTEIN)
1r5l PROTEIN
(ALPHA-TOCOPHEROL
TRANSFER PROTEIN)

(Homo
sapiens)
11 / 11 TRP A 122
SER A 136
LEU A 137
SER A 140
PHE A 158
ILE A 171
ILE A 179
VAL A 182
LEU A 183
PHE A 187
VAL A 191
None
VIV  A 301 (-3.5A)
VIV  A 301 ( 4.8A)
VIV  A 301 (-3.1A)
VIV  A 301 (-3.9A)
None
VIV  A 301 ( 4.0A)
VIV  A 301 (-4.5A)
None
VIV  A 301 (-3.9A)
VIV  A 301 (-4.7A)
0.68A 3w67A-1r5lA:
37.7
3w67A-1r5lA:
89.10
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3W67_B_VIVB301_0
(ALPHA-TOCOPHEROL
TRANSFER PROTEIN)
1r5l PROTEIN
(ALPHA-TOCOPHEROL
TRANSFER PROTEIN)

(Homo
sapiens)
11 / 12 ILE A 119
TRP A 122
SER A 136
LEU A 137
PHE A 158
TRP A 163
ILE A 171
ILE A 179
VAL A 182
LEU A 183
PHE A 187
None
None
VIV  A 301 (-3.5A)
VIV  A 301 ( 4.8A)
VIV  A 301 (-3.9A)
None
None
VIV  A 301 ( 4.0A)
VIV  A 301 (-4.5A)
None
VIV  A 301 (-3.9A)
0.67A 3w67B-1r5lA:
37.7
3w67B-1r5lA:
89.10
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3W67_B_VIVB301_0
(ALPHA-TOCOPHEROL
TRANSFER PROTEIN)
1r5l PROTEIN
(ALPHA-TOCOPHEROL
TRANSFER PROTEIN)

(Homo
sapiens)
6 / 12 ILE A 119
TRP A 122
SER A 136
LEU A 137
VAL A 191
PHE A 158
None
None
VIV  A 301 (-3.5A)
VIV  A 301 ( 4.8A)
VIV  A 301 (-4.7A)
VIV  A 301 (-3.9A)
1.49A 3w67B-1r5lA:
37.7
3w67B-1r5lA:
89.10
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3W67_C_VIVC301_0
(ALPHA-TOCOPHEROL
TRANSFER PROTEIN)
1r5l PROTEIN
(ALPHA-TOCOPHEROL
TRANSFER PROTEIN)

(Homo
sapiens)
12 / 12 TYR A 100
ILE A 119
TRP A 122
VAL A 132
LEU A 137
SER A 140
ALA A 156
PHE A 158
ILE A 179
LEU A 183
PHE A 187
VAL A 191
None
None
None
VIV  A 301 ( 4.7A)
VIV  A 301 ( 4.8A)
VIV  A 301 (-3.1A)
VIV  A 301 ( 4.4A)
VIV  A 301 (-3.9A)
VIV  A 301 ( 4.0A)
None
VIV  A 301 (-3.9A)
VIV  A 301 (-4.7A)
0.54A 3w67C-1r5lA:
37.3
3w67C-1r5lA:
89.10
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3W67_D_VIVD301_0
(ALPHA-TOCOPHEROL
TRANSFER PROTEIN)
1r5l PROTEIN
(ALPHA-TOCOPHEROL
TRANSFER PROTEIN)

(Homo
sapiens)
9 / 12 VAL A 132
SER A 136
LEU A 137
SER A 140
PHE A 158
VAL A 182
PHE A 187
ILE A 194
LEU A 196
VIV  A 301 ( 4.7A)
VIV  A 301 (-3.5A)
VIV  A 301 ( 4.8A)
VIV  A 301 (-3.1A)
VIV  A 301 (-3.9A)
VIV  A 301 (-4.5A)
VIV  A 301 (-3.9A)
VIV  A 301 ( 4.5A)
None
0.55A 3w67D-1r5lA:
37.0
3w67D-1r5lA:
89.10
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3W67_D_VIVD301_0
(ALPHA-TOCOPHEROL
TRANSFER PROTEIN)
1r5l PROTEIN
(ALPHA-TOCOPHEROL
TRANSFER PROTEIN)

(Homo
sapiens)
11 / 12 VAL A 132
SER A 136
SER A 140
PHE A 158
ILE A 171
ILE A 179
VAL A 182
LEU A 183
PHE A 187
ILE A 194
LEU A 196
VIV  A 301 ( 4.7A)
VIV  A 301 (-3.5A)
VIV  A 301 (-3.1A)
VIV  A 301 (-3.9A)
None
VIV  A 301 ( 4.0A)
VIV  A 301 (-4.5A)
None
VIV  A 301 (-3.9A)
VIV  A 301 ( 4.5A)
None
0.51A 3w67D-1r5lA:
37.0
3w67D-1r5lA:
89.10
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3W68_A_VIVA301_0
(ALPHA-TOCOPHEROL
TRANSFER PROTEIN)
1r5l PROTEIN
(ALPHA-TOCOPHEROL
TRANSFER PROTEIN)

(Homo
sapiens)
12 / 12 TYR A 100
TRP A 122
VAL A 132
SER A 136
LEU A 137
SER A 140
PHE A 158
ILE A 179
VAL A 182
LEU A 183
PHE A 187
VAL A 191
None
None
VIV  A 301 ( 4.7A)
VIV  A 301 (-3.5A)
VIV  A 301 ( 4.8A)
VIV  A 301 (-3.1A)
VIV  A 301 (-3.9A)
VIV  A 301 ( 4.0A)
VIV  A 301 (-4.5A)
None
VIV  A 301 (-3.9A)
VIV  A 301 (-4.7A)
0.44A 3w68A-1r5lA:
38.7
3w68A-1r5lA:
89.10
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3W68_B_VIVB301_0
(ALPHA-TOCOPHEROL
TRANSFER PROTEIN)
1r5l PROTEIN
(ALPHA-TOCOPHEROL
TRANSFER PROTEIN)

(Homo
sapiens)
9 / 12 TYR A 100
ILE A 119
TRP A 122
VAL A 132
SER A 136
LEU A 137
PHE A 158
PHE A 187
VAL A 191
None
None
None
VIV  A 301 ( 4.7A)
VIV  A 301 (-3.5A)
VIV  A 301 ( 4.8A)
VIV  A 301 (-3.9A)
VIV  A 301 (-3.9A)
VIV  A 301 (-4.7A)
0.45A 3w68B-1r5lA:
37.9
3w68B-1r5lA:
89.10
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3W68_B_VIVB301_0
(ALPHA-TOCOPHEROL
TRANSFER PROTEIN)
1r5l PROTEIN
(ALPHA-TOCOPHEROL
TRANSFER PROTEIN)

(Homo
sapiens)
9 / 12 TYR A 100
ILE A 119
TRP A 122
VAL A 132
SER A 136
LEU A 137
VAL A 191
PHE A 158
PHE A 187
None
None
None
VIV  A 301 ( 4.7A)
VIV  A 301 (-3.5A)
VIV  A 301 ( 4.8A)
VIV  A 301 (-4.7A)
VIV  A 301 (-3.9A)
VIV  A 301 (-3.9A)
1.40A 3w68B-1r5lA:
37.9
3w68B-1r5lA:
89.10
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3W68_B_VIVB301_0
(ALPHA-TOCOPHEROL
TRANSFER PROTEIN)
1r5l PROTEIN
(ALPHA-TOCOPHEROL
TRANSFER PROTEIN)

(Homo
sapiens)
10 / 12 TYR A 100
ILE A 119
TRP A 122
VAL A 132
SER A 136
PHE A 158
ILE A 179
LEU A 183
PHE A 187
VAL A 191
None
None
None
VIV  A 301 ( 4.7A)
VIV  A 301 (-3.5A)
VIV  A 301 (-3.9A)
VIV  A 301 ( 4.0A)
None
VIV  A 301 (-3.9A)
VIV  A 301 (-4.7A)
0.38A 3w68B-1r5lA:
37.9
3w68B-1r5lA:
89.10
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3W68_C_VIVC301_0
(ALPHA-TOCOPHEROL
TRANSFER PROTEIN)
1r5l PROTEIN
(ALPHA-TOCOPHEROL
TRANSFER PROTEIN)

(Homo
sapiens)
10 / 12 ILE A 119
TRP A 122
VAL A 132
PHE A 158
ILE A 171
ILE A 179
VAL A 182
LEU A 183
PHE A 187
VAL A 191
None
None
VIV  A 301 ( 4.7A)
VIV  A 301 (-3.9A)
None
VIV  A 301 ( 4.0A)
VIV  A 301 (-4.5A)
None
VIV  A 301 (-3.9A)
VIV  A 301 (-4.7A)
0.29A 3w68C-1r5lA:
37.3
3w68C-1r5lA:
89.10
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3W68_C_VIVC301_0
(ALPHA-TOCOPHEROL
TRANSFER PROTEIN)
1r5l PROTEIN
(ALPHA-TOCOPHEROL
TRANSFER PROTEIN)

(Homo
sapiens)
5 / 12 ILE A 119
TRP A 122
VAL A 132
VAL A 191
PHE A 158
None
None
VIV  A 301 ( 4.7A)
VIV  A 301 (-4.7A)
VIV  A 301 (-3.9A)
1.16A 3w68C-1r5lA:
37.3
3w68C-1r5lA:
89.10
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3W68_C_VIVC301_0
(ALPHA-TOCOPHEROL
TRANSFER PROTEIN)
1r5l PROTEIN
(ALPHA-TOCOPHEROL
TRANSFER PROTEIN)

(Homo
sapiens)
8 / 12 ILE A 119
VAL A 132
LEU A 137
PHE A 158
VAL A 182
LEU A 183
PHE A 187
VAL A 191
None
VIV  A 301 ( 4.7A)
VIV  A 301 ( 4.8A)
VIV  A 301 (-3.9A)
VIV  A 301 (-4.5A)
None
VIV  A 301 (-3.9A)
VIV  A 301 (-4.7A)
0.52A 3w68C-1r5lA:
37.3
3w68C-1r5lA:
89.10
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3W68_D_VIVD301_0
(ALPHA-TOCOPHEROL
TRANSFER PROTEIN)
1r5l PROTEIN
(ALPHA-TOCOPHEROL
TRANSFER PROTEIN)

(Homo
sapiens)
11 / 12 TYR A 100
TRP A 122
VAL A 132
LEU A 137
PHE A 158
ILE A 171
ILE A 179
VAL A 182
LEU A 183
PHE A 187
VAL A 191
None
None
VIV  A 301 ( 4.7A)
VIV  A 301 ( 4.8A)
VIV  A 301 (-3.9A)
None
VIV  A 301 ( 4.0A)
VIV  A 301 (-4.5A)
None
VIV  A 301 (-3.9A)
VIV  A 301 (-4.7A)
0.50A 3w68D-1r5lA:
36.8
3w68D-1r5lA:
89.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4K50_A_ACTA505_0
(RNA POLYMERASE
3D-POL)
1r5l PROTEIN
(ALPHA-TOCOPHEROL
TRANSFER PROTEIN)

(Homo
sapiens)
3 / 3 CYH A 256
ASN A 261
LYS A  97
None
0.72A 4k50A-1r5lA:
undetectable
4k50A-1r5lA:
21.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5IEN_A_VDYA201_2
(CDL2.2)
1r5l PROTEIN
(ALPHA-TOCOPHEROL
TRANSFER PROTEIN)

(Homo
sapiens)
5 / 12 ILE A 143
LEU A 115
ILE A 263
LEU A  96
GLY A  99
None
1.17A 5ienA-1r5lA:
undetectable
5ienA-1r5lA:
18.32
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MUE_A_VIVA302_0
(ALPHA-TOCOPHEROL
TRANSFER PROTEIN)
1r5l PROTEIN
(ALPHA-TOCOPHEROL
TRANSFER PROTEIN)

(Homo
sapiens)
12 / 12 ILE A 119
VAL A 132
ILE A 154
PHE A 158
TRP A 163
ILE A 179
VAL A 182
LEU A 183
PHE A 187
VAL A 191
ILE A 194
PHE A 203
None
VIV  A 301 ( 4.7A)
None
VIV  A 301 (-3.9A)
None
VIV  A 301 ( 4.0A)
VIV  A 301 (-4.5A)
None
VIV  A 301 (-3.9A)
VIV  A 301 (-4.7A)
VIV  A 301 ( 4.5A)
None
0.20A 5mueA-1r5lA:
39.2
5mueA-1r5lA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MUE_A_VIVA302_0
(ALPHA-TOCOPHEROL
TRANSFER PROTEIN)
1r5l PROTEIN
(ALPHA-TOCOPHEROL
TRANSFER PROTEIN)

(Homo
sapiens)
6 / 12 VAL A 135
PHE A 158
VAL A 182
LEU A 183
VAL A 191
ILE A 194
None
VIV  A 301 (-3.9A)
VIV  A 301 (-4.5A)
None
VIV  A 301 (-4.7A)
VIV  A 301 ( 4.5A)
1.21A 5mueA-1r5lA:
39.2
5mueA-1r5lA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MUG_A_VIVA301_0
(ALPHA-TOCOPHEROL
TRANSFER PROTEIN)
1r5l PROTEIN
(ALPHA-TOCOPHEROL
TRANSFER PROTEIN)

(Homo
sapiens)
12 / 12 ILE A 119
VAL A 132
LEU A 137
ILE A 154
TRP A 163
ILE A 179
VAL A 182
LEU A 183
PHE A 187
VAL A 191
ILE A 194
PHE A 203
None
VIV  A 301 ( 4.7A)
VIV  A 301 ( 4.8A)
None
None
VIV  A 301 ( 4.0A)
VIV  A 301 (-4.5A)
None
VIV  A 301 (-3.9A)
VIV  A 301 (-4.7A)
VIV  A 301 ( 4.5A)
None
0.42A 5mugA-1r5lA:
37.0
5mugA-1r5lA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MUG_A_VIVA301_1
(ALPHA-TOCOPHEROL
TRANSFER PROTEIN)
1r5l PROTEIN
(ALPHA-TOCOPHEROL
TRANSFER PROTEIN)

(Homo
sapiens)
3 / 3 SER A 136
SER A 140
PHE A 158
VIV  A 301 (-3.5A)
VIV  A 301 (-3.1A)
VIV  A 301 (-3.9A)
0.15A 5mugA-1r5lA:
37.0
5mugA-1r5lA:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ODQ_A_ACTA703_0
(HETERODISULFIDE
REDUCTASE, SUBUNIT A)
1r5l PROTEIN
(ALPHA-TOCOPHEROL
TRANSFER PROTEIN)

(Homo
sapiens)
4 / 6 ARG A  54
ARG A  57
ALA A  58
PRO A 188
None
1.22A 5odqA-1r5lA:
undetectable
5odqA-1r5lA:
17.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TL8_A_X2NA502_1
(PROTEIN CYP51)
1r5l PROTEIN
(ALPHA-TOCOPHEROL
TRANSFER PROTEIN)

(Homo
sapiens)
5 / 12 PHE A 237
PHE A 158
ALA A 176
ALA A 180
THR A 184
None
VIV  A 301 (-3.9A)
None
None
None
1.24A 5tl8A-1r5lA:
undetectable
5tl8A-1r5lA:
18.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VKQ_B_PCFB1806_0
(NO MECHANORECEPTOR
POTENTIAL C ISOFORM
L)
1r5l PROTEIN
(ALPHA-TOCOPHEROL
TRANSFER PROTEIN)

(Homo
sapiens)
4 / 6 ILE A 197
ILE A 154
PHE A 237
HIS A 236
None
0.91A 5vkqB-1r5lA:
undetectable
5vkqC-1r5lA:
undetectable
5vkqB-1r5lA:
9.57
5vkqC-1r5lA:
9.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VKQ_C_PCFC1807_0
(NO MECHANORECEPTOR
POTENTIAL C ISOFORM
L)
1r5l PROTEIN
(ALPHA-TOCOPHEROL
TRANSFER PROTEIN)

(Homo
sapiens)
4 / 6 ILE A 197
ILE A 154
PHE A 237
HIS A 236
None
0.90A 5vkqC-1r5lA:
undetectable
5vkqD-1r5lA:
undetectable
5vkqC-1r5lA:
9.57
5vkqD-1r5lA:
9.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ZRD_C_CUC604_0
(TYROSINASE)
1r5l PROTEIN
(ALPHA-TOCOPHEROL
TRANSFER PROTEIN)

(Homo
sapiens)
4 / 4 HIS A 195
HIS A 236
HIS A 225
HIS A 223
None
1.09A 5zrdC-1r5lA:
undetectable
5zrdC-1r5lA:
18.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ZRD_D_CUD607_0
(TYROSINASE)
1r5l PROTEIN
(ALPHA-TOCOPHEROL
TRANSFER PROTEIN)

(Homo
sapiens)
4 / 4 HIS A 195
HIS A 236
HIS A 225
HIS A 223
None
1.07A 5zrdD-1r5lA:
undetectable
5zrdD-1r5lA:
18.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AZ3_1_PAR11801_1
(RRNA ALPHA
RIBOSOMAL PROTEIN
EL18)
1r5l PROTEIN
(ALPHA-TOCOPHEROL
TRANSFER PROTEIN)

(Homo
sapiens)
4 / 4 ARG A 221
ARG A 192
GLY A 111
ARG A 107
None
1.49A 6az3P-1r5lA:
0.0
6az3P-1r5lA:
11.60